MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

@article{Watson2015MicroRNASD,
  title={MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure},
  author={C. Watson and S. Gupta and Eoin O'Connell and S. Thum and N. Glezeva and Jasmin Fendrich and J. Gallagher and M. Ledwidge and L. Grote-Levi and K. McDonald and T. Thum},
  journal={European Journal of Heart Failure},
  year={2015},
  volume={17},
  pages={405 - 415}
}
  • C. Watson, S. Gupta, +8 authors T. Thum
  • Published 2015
  • Medicine
  • European Journal of Heart Failure
  • Differentiation of heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction independent of echocardiography is challenging in the community. Diagnostic strategies based on monitoring circulating microRNA (miRNA) levels may prove to be of clinical value in the near future. The aim of this study was to identify a novel miRNA signature that could be a useful HF diagnostic tool and provide valuable clinical information on whether a patient has HFrEF or HFpEF. 
    116 Citations
    Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels
    • 18
    Diagnostic value of circulating microRNA‐19b in heart failure
    Targets for Heart Failure With Preserved Ejection Fraction
    • 11
    • Highly Influenced
    Redefining biomarkers in heart failure
    • 14

    References

    SHOWING 1-10 OF 39 REFERENCES
    Non-coding RNAs in cardiac remodeling and heart failure.
    • 202
    • PDF
    State of the art: Using natriuretic peptide levels in clinical practice
    • 674
    • PDF
    Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction
    • 92